Genetic determinants of urolithiasis (original) (raw)

• Clubbe, W. H. Hereditariness of stone. Lancet 99, 204 (1872).
  Article Google Scholar
• Clubbe, W. H. Family disposition to urinary concretions. Lancet 104, 823 (1874).
  Google Scholar
• Thorleifsson, G. et al. Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density. Nat. Genet. 41, 926–930 (2009).
  Article CAS PubMed Google Scholar
• Weber, S. et al. Novel paracellin-1 mutations in 25 families with familial hypomagnesemia with hypercalciuria and nephrocalcinosis. J. Am. Soc. Nephrol. 12, 1872–1881 (2001).
  CAS PubMed Google Scholar
• Konrad, M. et al. Mutations in the tight-junction gene claudin 19 (CLDN19) are associated with renal magnesium wasting, renal failure, and severe ocular involvement. Am. J. Hum. Genet. 79, 949–957 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Johnson, C. M., Wilson, D. M., O'Fallon, W. M., Malek, R. S. & Kurland, L. T. Renal stone epidemiology: a 25-year study in Rochester, Minnesota. Kidney Int. 16, 624–631 (1979).
  Article CAS PubMed Google Scholar
• Soucie, J. M., Thun, M. J., Coates, R. J., McClellan, W. & Austin, H. Demographic and geographic variability of kidney stones in the United States. Kidney Int. 46, 893–899 (1994).
  Article CAS PubMed Google Scholar
• Hiatt, R. A. & Friedman, G. D. The frequency of kidney and urinary tract diseases in a defined population. Kidney Int. 22, 63–68 (1982).
  Article CAS PubMed Google Scholar
• Ljunghall, S. Renal stone disease. Studies of epidemiology and calcium metabolism. Scand. J. Urol. Nephrol. 41, 1–96 (1977).
  Google Scholar
• Sutherland, J. W., Parks, J. H. & Coe, F. L. Recurrence after a single renal stone in a community practice. Miner. Electrolyte Metab. 11, 267–269 (1985).
  CAS PubMed Google Scholar
• Marshall, V., White, R. H., De Saintonge, M. C., Tresidder, G. C. & Blandy, J. P. The natural history of renal and ureteric calculi. Br. J. Urol. 47, 117–124 (1975).
  Article CAS PubMed Google Scholar
• Stamatelou, K. K., Francis, M. E., Jones, C. A., Nyberg, L. M. & Curhan, G. C. Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int. 63, 1817–1823 (2003).
  Article PubMed Google Scholar
• Strohmaier, W. L. Course of calcium stone disease without treatment. What can we expect? Eur. Urol. 37, 339–344 (2000).
  Article CAS PubMed Google Scholar
• Gambaro, G., Favaro, S. & D'Angelo, A. Risk for renal failure in nephrolithiasis. Am. J. Kidney Dis. 37, 233–243 (2001).
  Article CAS PubMed Google Scholar
• Worcester, E., Park, J. H., Josephson, M. A., Thisted, R. A. & Coe, F. L. Causes and consequences of kidney loss in patients with nephrolithiasis. Kidney Int. 64, 2204–2213 (2003).
  Article CAS PubMed Google Scholar
• Worcester, E. M., Parks, J. H., Evan, A. P. & Coe, F. L. Renal function in patients with nephrolithiasis. J. Urol. 176, 600–603 (2006).
  Article PubMed Google Scholar
• Saucier, N. A. et al. Risk factors for CKD in persons with kidney stones: a case-control study in Olmsted County, Minnesota. Am. J. Kidney Dis. 55, 61–68 (2010).
  Article PubMed Google Scholar
• Henneman, P. H., Benedict, P. H., Forbes, A. P. & Dudley, H. R. Idiopathic hypercalciuria. N. Engl. J. Med. 259, 802–807 (1958).
  Article CAS PubMed Google Scholar
• Resnick, M., Pridgen, D. B. & Goodman, H. O. Genetic predisposition to formation of calcium oxalate renal calculi. N. Engl. J. Med. 278, 1313–1318 (1968).
  Article CAS PubMed Google Scholar
• Coe, F. L., Parks, J. H. & Moore, E. S. Familial idiopathic hypercalciuria. N. Engl. J. Med. 300, 337–340 (1979).
  Article CAS PubMed Google Scholar
• Curhan, G. C., Willett, W. C., Rimm, E. B. & Stampfer, M. J. Family history and risk of kidney stones. J. Am. Soc. Nephrol. 8, 1568–1573 (1997).
  CAS PubMed Google Scholar
• McGeown, M. G. Heredity in renal stone disease. Clin. Sci. 19, 465–471 (1960).
  CAS PubMed Google Scholar
• Stechman, M. J., Loh, N. Y. & Thakker, R. V. Genetics of hypercalciuric nephrolithiasis: renal stone disease. Ann. NY Acad. Sci. 1116, 461–484 (2007).
  Article CAS PubMed Google Scholar
• Goldfarb, D. S., Fischer, M. E., Keich, Y. & Goldberg, J. A twin study of genetic and dietary influences on nephrolithiasis: a report from the Vietnam Era Twin (VET) Registry. Kidney Int. 67, 1053–1061 (2005).
  Article PubMed Google Scholar
• Hunter, D. J. et al. Genetic contribution to renal function and electrolyte balance: a twin study. Clin. Sci. (Lond.) 103, 259–265 (2002).
  Article CAS Google Scholar
• Monga, M., Macias, B., Groppo, E. & Hargens, A. Genetic heritability of urinary stone risk in identical twins. J. Urol. 175, 2125–2128 (2006).
  Article PubMed Google Scholar
• Herring, L. C. Observations on the analysis of ten thousand urinary calculi. J. Urol. 88, 545–562 (1962).
  Article CAS PubMed Google Scholar
• Hoopes, R. R. Jr et al. Quantitative trait loci for hypercalciuria in a rat model of kidney stone disease. J. Am. Soc. Nephrol. 14, 1844–1850 (2003).
  Article CAS PubMed Google Scholar
• Bushinsky, D. A. Genetic hypercalciuric stone-forming rats. Curr. Opin. Nephrol. Hypertens. 8, 479–488 (1999).
  Article CAS PubMed Google Scholar
• Favus, M. J., Karnauskas, A. J., Parks, J. H. & Coe, F. L. Peripheral blood monocyte vitamin D receptor levels are elevated in patients with idiopathic hypercalciuria. J. Clin. Endocrinol. Metab. 89, 4937–4943 (2004).
  Article CAS PubMed Google Scholar
• Bai, S. et al. Elevated vitamin D receptor levels in genetic hypercalciuric stone-forming rats are associated with down-regulation of Snail. J. Bone Miner. Res. 25, 830–840 (2010).
  CAS PubMed Google Scholar
• Scott, P. et al. Suggestive evidence for a susceptibility gene near the vitamin D receptor locus in idiopathic calcium stone formation. J. Am. Soc. Nephrol. 10, 1007–1013 (1999).
  CAS PubMed Google Scholar
• Relan, V., Khullar, M., Singh, S. K. & Sharma, S. K. Association of vitamin D receptor genotypes with calcium excretion in nephrolithiatic subjects in northern India. Urol. Res. 32, 236–240 (2004).
  Article CAS PubMed Google Scholar
• Heilberg, I. P., Teixeira, S. H., Martini, L. A. & Boim, M. A. Vitamin D receptor gene polymorphism and bone mineral density in hypercalciuric calcium-stone-forming patients. Nephron 90, 51–57 (2002).
  Article CAS PubMed Google Scholar
• Vezzoli, G. et al. R990G polymorphism of calcium-sensing receptor does produce a gain-of-function and predispose to primary hypercalciuria. Kidney Int. 71, 1155–1162 (2007).
  Article CAS PubMed Google Scholar
• Petrucci, M. et al. Evaluation of the calcium-sensing receptor gene in idiopathic hypercalciuria and calcium nephrolithiasis. Kidney Int. 58, 38–42 (2000).
  Article CAS PubMed Google Scholar
• Reed, B. Y., Heller, H. J., Gitomer, W. L. & Pak, C. Y. Mapping a gene defect in absorptive hypercalciuria to chromosome 1q23.3-q24. J. Clin. Endocrinol. Metab. 84, 3907–3913 (1999).
  CAS PubMed Google Scholar
• Reed, B. Y. et al. Identification and characterization of a gene with base substitutions associated with the absorptive hypercalciuria phenotype and low spinal bone density. J. Clin. Endocrinol. Metab. 87, 1476–1485 (2002).
  Article CAS PubMed Google Scholar
• Hoenderop, J. G. et al. Molecular identification of the apical Ca2+ channel 1,25-dihydroxyvitamin D3-responsive epithelia. J. Biol. Chem. 274, 8375–8378 (1999).
  Article CAS PubMed Google Scholar
• Müller, D. et al. Epithelial Ca2+ channel (ECAC1) in autosomal dominant idiopathic hypercalciuria. Nephrol. Dial. Transplant. 17, 1614–1620 (2002).
  Article PubMed Google Scholar
• Jiang, Y., Ferguson, W. B. & Peng, J. B. WNK4 enhances TRPV5-mediated calcium transport: potential role in hypercalciuria of familial hyperkalemic hypertension caused by gene mutation of WNK4. Am. J. Physiol. Renal Physiol. 292, F545–F554 (2007).
  Article CAS PubMed Google Scholar
• Hoenderop, J. G. et al. Renal Ca2+ wasting, hyperabsorption, and reduced bone thickness in mice lacking TRPV5. J. Clin. Invest. 112, 1906–1914 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Peng, J. B., Brown, E. M. & Hediger, M. A. Structural conservation of the genes encoding CaT1, CaT2, and related cation channels. Genomics 76, 99–109 (2001).
  Article CAS PubMed Google Scholar
• Renkema, K. Y. et al. TRPV5 gene polymorphisms in renal hypercalciuria. Nephrol. Dial. Transplant. 24, 1919–1924 (2009).
  Article CAS PubMed Google Scholar
• Ryall, R. L. Macromolecules and urolithiasis: parallels and paradoxes. Nephron Physiol. 98, 37–42 (2004).
  Article Google Scholar
• Khan, S. R. & Kok, D. J. Modulators of urinary stone formation. Front. Biosci. 9, 1450–1482 (2004).
  Article CAS PubMed Google Scholar
• Hess, B. Tamm-Horsfall glycoprotein and calcium nephrolithiasis. Miner. Electrolyte Metab. 20, 393–398 (1994).
  CAS PubMed Google Scholar
• Ryall, R. L. Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation. World J. Urol. 15, 155–164 (1997).
  Article CAS PubMed Google Scholar
• Gao, B. et al. Association of osteopontin gene haplotypes with nephrolithiasis. Kidney Int. 72, 592–598 (2007).
  Article CAS PubMed Google Scholar
• Gögebakan, B. et al. Association between the T-593A and C6982T polymorphisms of the osteopontin gene and risk of developing nephrolithiasis. Arch. Med. Res. 41, 442–448 (2010).
  Article PubMed CAS Google Scholar
• Liu, C. C. et al. The impact of osteopontin promoter polymorphisms on the risk of calcium urolithiasis. Clin. Chim. Acta 411, 739–743 (2010).
  Article CAS PubMed Google Scholar
• Okamoto, N. et al. Associations between renal sodium-citrate cotransporter (hNaDC-1) gene polymorphism and urinary citrate excretion in recurrent renal calcium stone formers and normal controls. Int. J. Urol. 14, 344–349 (2007).
  Article CAS PubMed Google Scholar
• Wilcox, E. R. et al. Mutations in gene encoding tight junction claudin-14 cause autosomal recessive deafness DFNB29. Cell 104, 165–172 (2001).
  Article CAS PubMed Google Scholar
• Jungers, P. et al. Inherited monogenic kidney stone diseases: recent diagnostic and therapeutic advances [French]. Nephrol. Ther. 4, 231–255 (2008).
  Article CAS PubMed Google Scholar
• Milliner, D. S. in Requisite in Pediatrics: Pediatric Nephrology and Urology (eds Kaplan, B. S. & Myers, K.) 361–374 (Mosby, St Louis, 2004).
  Google Scholar
• Wrong, O. M., Norden, A. G. & Feest, T. G. Dent's disease; a familial proximal renal tubular syndrome with low-molecuar-weight proteinuria, hypercalciuria, nephrocalcinosis, metabolic bone disease, progressive renal failure and a marked male predominance. QJM 87, 473–493 (1994).
  CAS PubMed Google Scholar
• Lloyd, S. E. et al. A common molecular basis for three inherited kidney stone diseases. Nature 379, 445–449 (1996).
  Article CAS PubMed Google Scholar
• Hoopes, R. R. Jr et al. Dent disease with mutations in OCRL1. Am. J. Hum. Genet. 76, 260–267 (2005).
  Article CAS PubMed Google Scholar
• Lowe, M. Structure and function of the Lowe syndrome protein OCRL1. Traffic 6, 711–719 (2005).
  Article CAS PubMed Google Scholar
• Sliman, G. A., Winters, W. D., Shaw, D. W. & Avner, E. D. Hypercalciuria and nephrocalcinosis in the oculocerebrorenal syndrome. J. Urol. 153, 1244–1246 (1995).
  Article CAS PubMed Google Scholar
• Utsch, B. et al. Novel OCRL1 mutations in patients with the phenotype of Dent disease. Am. J. Kidney Dis. 48, 942–954 (2006).
  Article CAS PubMed Google Scholar
• Tosetto, E. et al. Phenotypic and genetic heterogeneity in Dent's disease—results of an Italian collaborative study. Nephrol. Dial. Transplant. 21, 2452–2463 (2006).
  Article CAS PubMed Google Scholar
• Scheinman, S. J. X-linked hypercalciuric nephrolithiasis: clinical syndromes and chloride channel mutations. Kidney Int. 53, 3–17 (1998).
  Article CAS PubMed Google Scholar
• Scheinman, S. J. et al. Isolated hypercalciuria with mutation in CLCN5: relevance to idiopathic hypercalciuria. Kidney Int. 57, 232–239 (2000).
  Article CAS PubMed Google Scholar
• Colegio, O. R., Van Itallie, C. M., McCrea, H. J., Rahner, C. & Anderson, J. M. Claudins create charge-selective channels in the paracellular pathway between epithelial cells. Am. J. Physiol. Cell Physiol. 283, C142–C147 (2002).
  Article CAS PubMed Google Scholar
• Simon, D. B. et al. Paracellin-1, a renal tight junction protein required for paracellular Mg2+ resorption. Science 285, 103–106 (1999).
  Article CAS PubMed Google Scholar
• Hou, J. et al. Claudin-16 and claudin-19 interaction is required for their assembly into tight junctions and for renal reabsorption of magnesium. Proc. Natl Acad. Sci. USA 106, 15350–15355 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Konrad, M. et al. CLDN16 genotype predicts renal decline in familial hypomagnesemia with hypercalciuria and nephrocalcinosis. J. Am. Soc. Nephrol. 19, 171–181 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Müller, D. et al. A novel claudin 16 mutation associated with childhood hypercalciuria abolishes binding to ZO-1 and results in lysosomal mistargeting. Am J. Hum. Genet. 73, 1293–1301 (2003).
  Article PubMed PubMed Central Google Scholar
• Bruce, L. J., Unwin, R. J., Wrong, O. & Tanner, M. J. The association between familial distal renal tubular acidosis and mutations in the red cell anion exchanger (band 3, AE1) gene. Biochem. Cell Biol. 76, 723–728 (1998).
  Article CAS PubMed Google Scholar
• Cheidde, L., Vieira, T. C., Lima, P. R., Saad, S. T. & Heilberg, I. P. A novel mutation in the anion exchanger 1 gene is associated with familial distal renal tubular acidosis and nephrocalcinosis. Pediatrics 112, 1361–1367 (2003).
  Article PubMed Google Scholar
• Karet, F. E. et al. Localization of a gene for autosomal recessive distal renal tubular acidosis with normal hearing (rdRTA2) to 7q33–34. Am. J. Hum. Genet. 65, 1656–1665 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Karet, F. E. et al. Mutations in the gene encoding B1 subunit of H+-ATPase cause renal tubular acidosis with sensorineural deafness. Nat. Genet. 21, 84–90 (1999).
  Article CAS PubMed Google Scholar
• Smith, A. N. et al. Mutations in ATP6N1B, encoding a new kidney vacuolar proton pump 116-kD subunit, cause recessive distal renal tubular acidosis with preserved hearing. Nat. Genet. 26, 71–75 (2000).
  Article CAS PubMed Google Scholar
• Stover, E. H. et al. Novel ATP6V1B1 and ATP6V0A4 mutations in autosomal recessive distal renal tubular acidosis with new evidence for hearing loss. J. Med. Genet. 39, 796–803 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Tieder, M. et al. Hereditary hypophosphatemic rickets with hypercalciuria. N. Engl. J. Med. 312, 611–617 (1985).
  Article CAS PubMed Google Scholar
• Bergwitz, C. et al. SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis. Am. J. Hum. Genet. 78, 179–192 (2006).
  Article CAS PubMed Google Scholar
• Lorenz-Depiereux, B. et al. Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium-phosphate cotransporter gene SLC34A3. Am. J. Hum. Genet. 78, 193–201 (2006).
  Article CAS PubMed Google Scholar
• Jaureguiberry, G., Carpenter, T. O., Forman, S., Jüppner, H. & Bergwitz, C. A novel missense mutation in SLC34A3 that causes hereditary hypophosphatemic rickets with hypercalciuria in humans identifies threonine 137 as an important determinant of sodium-phosphate cotransport in NaPi-IIc. Am. J. Physiol. Renal Physiol. 295, F371–F379 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Tencza, A. L. et al. Hypophosphatemic rickets with hypercalciuria due to mutation in SLC34A3/type IIc sodium-phosphate cotransporter: presentation as hypercalciuria and nephrolithiasis. J. Clin. Endocrinol. Metab. 94, 4433–4438 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Ichikawa, S. et al. Intronic deletions in the SLC34A3 gene cause hereditary hypophosphatemic rickets with hypercalciuria. J. Clin. Endocrinol. Metab. 91, 4022–4027 (2006).
  Article CAS PubMed Google Scholar
• Simmons, H. A., Sahota, A. S. & Van Acker, K. J. in The Metabolic Basis of Inherited Disease 6th edn (eds Scriver, C. R., Beaudet, A. L., Sly, W. S. & Valle, D.) 1029–1044 (McGraw-Hill, New York, 1989).
  Google Scholar
• Edvardsson, V., Palsson, R., Olafsson, I., Hjaltadottir, G. & Laxdal, T. Clinical features and genotype of adenine phosphoribosyltransferase deficiency in Iceland. Am. J. Kidney Dis. 38, 473–480 (2001).
  Article CAS PubMed Google Scholar
• Sahota, A. S., Tischfield, J. A., Kamatani, N. & Simmonds, H. A. in The Metabolic and Molecular Bases of Inherited Disease 8th edn (eds Scriver, C. R. et al.) 2571–2584 (McGraw-Hill, New York, 2000).
  Google Scholar
• Kamatani, N. et al. Identification of a compound heterozygote for adenine phosphoribosyltransferase deficiency (APRT*J/APART*Q0) leading to 2,8-dihydroxyadenine urolithiasis. Hum. Genet. 85, 500–504 (1990).
  CAS PubMed Google Scholar
• Gathof, B. S. et al. A splice mutation at the adenine phosphoribosyltransferase locus detected in a German family. Adv. Exp. Med. Biol. 309B, 83–86 (1991).
  Article CAS PubMed Google Scholar
• Menardi, C. et al. Human APRT deficiency indication for multiple origins of the most common Caucasian mutation and detection of a novel type of mutation involving intrastrand-templated repair. Hum. Mutat. 10, 251–255 (1997).
  Article CAS PubMed Google Scholar
• Bollée, G. et al. Phenotype and genotype characterization of adenine phosphoribosyltransferase deficiency. J. Am. Soc. Nephrol. 21, 679–688 (2010).
  Article PubMed PubMed Central CAS Google Scholar
• Di Pietro, V. et al. Clinical, biochemical and molecular diagnosis of a compound homozygote for the 254 bp deletion-8 bp insertion of the APRT gene suffering from severe renal failure. Clin. Biochem. 40, 73–80 (2007).
  Article CAS PubMed Google Scholar
• Johnson, L. A., Gordon, R. B. & Emmerson, B. T. Adenine phosphoribosyltransferase: a simple spectrophotometric assay and the incidence of mutation in the normal population. Biochem. Genet. 15, 265–272 (1977).
  Article CAS PubMed Google Scholar
• Seegmiller, J. E., Rosenbloom, F. M. & Kelley, W. N. Enzyme defect associated with a sex-linked human neurological disorder and excessive purine synthesis. Science 155, 1682–1684 (1967).
  Article CAS PubMed Google Scholar
• Kelley, W. N., Rosenbloom, F. M., Henderson, J. F. & Seegmiller, J. E. A specific enzyme defect in gout associated with overproduction of uric acid. Proc. Natl Acad. Sci. USA 57, 1735–1739 (1967).
  Article CAS PubMed PubMed Central Google Scholar
• Torres, R. J., Prior, C. & Puig, J. G. Efficacy and safety of allopurinol in patients with hypoxanthine-guanine phosphoribosyltransferase deficiency. Metabolism 56, 1179–1186 (2007).
  Article CAS PubMed Google Scholar
• Jinnah, H. A., De Gregorio, L., Harris, J. C., Nyhan, W. L. & O'Neill, J. P. The spectrum of inherited mutations causing HPRT deficiency: 75 new cases and a review of 196 previously reported cases. Mutat. Res. 463, 309–326 (2000).
  Article CAS PubMed Google Scholar
• Torres, R. J. et al. Molecular basis of hypoxanthine-guanine phosphoribosyltransferase deficiency in thirteen Spanish families. Hum. Mutat. 15, 383 (2000).
  Article CAS PubMed Google Scholar
• Torres, R. J. & Puig, J. G. Hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency: Lesch-Nyhan syndrome. Orphanet J. Rare Dis. 2, 48 (2007).
  Article PubMed PubMed Central Google Scholar
• Nyhan, W. L., Vuong, L. U. & Broock, R. Prenatal diagnosis of Lesch-Nyhan disease. Prenat. Diagn. 23, 807–809 (2003).
  Article PubMed Google Scholar
• Graham, G. W., Aitken, D. A. & Connor, J. M. Prenatal diagnosis by enzyme analysis in 15 pregnancies at risk for the Lesch-Nyhan syndrome. Prenat. Diag. 16, 647–651 (1996).
  Article CAS Google Scholar
• Ishida, Y. et al. Partial hypoxanthine-guanine phosphoribosyltransferase deficiency due to a newly recognized mutation presenting with renal failure in a one-year-old boy. Eur. J. Pediatr. 167, 957–959 (2008).
  Article PubMed Google Scholar
• Arikyants, N. et al. Xanthinuria type 1: a rare cause of urolithiasis. Pediatr. Nephrol. 22, 310–314 (2007).
  Article PubMed Google Scholar
• Cochat, P. et al. Epidemiology of primary hyperoxaluria type 1. Société de Néphrologie and the Société de Néphrologie Pédiatrique. Nephrol. Dial. Transplant. 10 (Suppl. 8), 3–7 (1995).
  Article PubMed Google Scholar
• Lieske, J. C. et al. International registry for primary hyperoxaluria. Am. J. Nephrol. 25, 290–296 (2005).
  Article PubMed Google Scholar
• Milliner, D. S. The primary hyperoxalurias: an algorithm for diagnosis. Am. J. Nephrol. 25, 154–160 (2005).
  Article PubMed Google Scholar
• Danpure, C. J. & Jennings, P. R. Peroxisomal alanine:glyoxylate aminotransferase deficiency in primary hyperoxaluria type 1. FEBS Lett. 26, 20–34 (1986).
  Article Google Scholar
• Rumsby, G., Williams, E. & Coulter-Mackie, M. Evaluation of mutation screening as a first line test for the diagnosis of primary hyperoxalurias. Kidney Int. 66, 959–963 (2004).
  Article CAS PubMed Google Scholar
• Williams, E. & Rumsby, G. Selected exonic sequencing of the AGXT gene provides a genetic diagnosis in 50% of patients with primary hyperoxaluria type 1. Clin. Chem. 53, 1216–1221 (2007).
  Article CAS PubMed Google Scholar
• Monico, C. G. et al. Comprehensive mutation screening in 55 probands with type 1 primary hyperoxaluria shows feasibility of a gene-based diagnosis. J. Am. Soc. Nephrol. 18, 1905–1914 (2007).
  Article CAS PubMed Google Scholar
• Williams, E. L. et al. Primary hyperoxaluria type 1: update and additional mutation analysis of the AGXT gene. Hum. Mutat. 30, 910–917 (2009).
  Article CAS PubMed Google Scholar
• Monico, C. G., Rossetti, S., Olson, J. B. & Milliner, D. S. Pyridoxine effect in type I primary hyperoxaluria is associated with the most common mutant allele. Kidney Int. 67, 1704–1709 (2005).
  Article CAS PubMed Google Scholar
• Monico, C. G., Olson, J. B. & Milliner, D. S. Implications of genotype and enzyme phenotype in pyridoxine response of patients with type I primary hyperoxaluria. Am. J. Nephrol. 25, 183–188 (2005).
  Article CAS PubMed Google Scholar
• Milliner, D. S., Eickholt, J. T., Bergstralh, E. J., Wilson, D. M. & Smith, L. H. Results of long-term treatment with orthophosphate and pyridoxine in patients with primary hyperoxaluria. N. Engl. J. Med. 331, 1553–1558 (1994).
  Article CAS PubMed Google Scholar
• Giafi, C. F. & Rumsby, G. Kinetic analysis and tissue distribution of human D-glycerate dehydrogenase/glyoxylate reductase and its relevance to the diagnosis of primary hyperoxaluria type 2. Ann. Clin. Biochem. 35, 104–109 (1998).
  Article CAS PubMed Google Scholar
• Milliner, D. S., Wilson, D. M. & Smith, L. H. Phenotypic expression of primary hyperoxaluria: comparative features of types I and II. Kidney Int. 59, 31–36 (2001).
  Article CAS PubMed Google Scholar
• Williams, H. E. & Smith, L. H. Jr. L-glyceric aciduria—a new genetic variant of primary hyperoxaluria. N. Engl. J. Med. 278, 233–238 (1968).
  Article CAS PubMed Google Scholar
• Webster, K. E., Ferree, P. M., Holmes, R. P. & Cramer, S. D. Identification of missense, nonsense, and deletion mutations in the GRHPR gene in patients with primary hyperoxaluria type II (PH2). Hum. Genet. 107, 176–185 (2000).
  Article CAS PubMed Google Scholar
• Cregeen, D. P., Williams, E. L., Hulton, S. & Rumsby, G. Molecular analysis of the glyoxylate reductase (GRHPR) gene and description of mutations underlying primary hyperoxaluria type 2. Hum. Mutat. 22, 497 (2003).
  Article PubMed CAS Google Scholar
• Monico, C. G., Persson, M., Ford, G. C., Rumsby, G. & Milliner, D. S. Potential mechanisms of marked hyperoxaluria not due to primary hyperoxaluria I or II. Kidney Int. 62, 392–400 (2002).
  Article CAS PubMed Google Scholar
• Belostotsky, R. et al. Mutations in DHDPSL are responsible for primary hyperoxaluria type III. Am. J. Hum. Genet. 87, 392–399 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Monico, C. G. et al. Primary hyperoxaluria type III gene HOGA1 (formerly DHDPSL) as a possible risk factor for idiopathic calcium oxalate urolithiasis. Clin. J. Am. Soc. Nephrol. 6, 2289–2295 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Calonge, M. J. et al. Cystinuria caused by mutations in rBAT, a gene involved in the transport of cystine. Nat. Genet. 6, 420–425 (1994).
  Article CAS PubMed Google Scholar
• Purroy, J. et al. Genomic structure and organization of the human rBAT gene (SLC3A1). Genomics 37, 249–252 (1996).
  Article CAS PubMed Google Scholar
• Chesney, R. W. Mutational analysis of patients with cystinuria detected by a genetic screening network: powerful tools in understanding the several forms of the disorder. Kidney Int. 54, 279–280 (1998).
  Article CAS PubMed Google Scholar
• Feliubadaló, L. et al. Non-type I cystinuria caused by mutations in SLC7A9, encoding a subunit (bo,+AT) of rBAT. Nat. Genet. 23, 52–57 (1999).
  Article PubMed Google Scholar
• Bruno, M. & Marangella, M. Cystinuria: recent advances in pathophysiology and genetics. Contrib. Nephrol. 122, 173–177 (1997).
  Article CAS PubMed Google Scholar
• Goodyer, P., Boutros, M. & Rozen, R. The molecular basis of cystinuria: an update. Exp. Nephrol. 8, 123–127 (2000).
  Article CAS PubMed Google Scholar
• Dello Strologo, L. et al. Comparison between SLC3A1 and SLC7A9 cystinuria patients and carriers: a need for a new classification. J. Am. Soc. Nephrol. 13, 2547–2553 (2002).
  Article PubMed Google Scholar
• Bisceglia, L. et al. Large rearrangements detected by MLPA, point mutations, and survey of the frequency of mutations within the SLC3A1 and SLC7A9 genes in a cohort of 172 cystinuric Italian patients. Mol. Genet. Metab. 99, 42–52 (2010).
  Article CAS PubMed Google Scholar
• Hoppe, B. & Langman, C. B. A United States survey on diagnosis, treatment, and outcome of primary hyperoxaluria. Pediatr. Nephrol. 18, 986–991 (2003).
  Article PubMed Google Scholar
• Nasr, S. H. et al. Crystalline nephropathy due to 2,8-dihydroxyadeninuria: an under-recognized cause of irreversible renal failure. Nephrol. Dial. Transplant. 25, 1909–1915 (2010).
  Article CAS PubMed Google Scholar